tert-Butyl (6-bromobenzo[d]thiazol-2-yl)carbamate

Catalog No. :
ACWACT891
CAS No. :
1244041-71-1
Molecular Formula :
C12H13BrN2O2S
Molecular Weight :
329.22

IUPAC Name:tert-butyl (6-bromobenzo[d]thiazol-2-yl)carbamate

tert-Butyl (6-bromobenzo[d]thiazol-2-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$79.00Login to see priceIn stockIn stock
5g97%$278.00Login to see priceIn stockIn stock
10g97%$501.00Login to see priceIn stockIn stock
25g97%$1190.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (6-bromobenzo[d]thiazol-2-yl)carbamate
IUPAC Nametert-butyl (6-bromobenzo[d]thiazol-2-yl)carbamate
MDL No.0
Molecular FormulaC12H13BrN2O2S
Molecular Weight329.22
SMILESO=C(OC(C)(C)C)NC1=NC2=CC=C(Br)C=C2S1
InChI KeyBIRRUNIKTIVYSQ-UHFFFAOYSA-N
Synonym(6-BroMo-benzothiazol-2-yl)-carbaMic acid tert-butyl ester;tert-butyl 6-bromobenzo[d]thiazol-2-ylcarbamate;Carbamic acid, N-(6-bromo-2-benzothiazolyl)-, 1,1-dimethylethyl ester;tert-butyl N-(6-bromo-1,3-benzothiazol-2-yl)carbamate
CAS No.1244041-71-1
PubChem CID77231294

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACWACT891 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWACT891 route product structure diagram
    ACWACT8911244041-71-1 In Stock
Inquiry

2. ACWACT891 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSCYU023 route compound structure diagram
    ACSCYU023857970-06-0 In Stock
  2. Then
  3. ACWACT891 route product structure diagram
    ACWACT8911244041-71-1 In Stock
Inquiry

Comments (0)